BIRC5 and breast cancer: As BIRC5 encodes the IAP family member protein survivin, which is implicated in resistance of breast cancer to apoptosis [24], its downregulation could sensitize paclitaxel-residual cells to pro-apoptotic drugs, like the SMAC mimetics.